Klinikum Stuttgart- New Principal Investigator

As of 2 June 2026, Dr. Markus Krautter has assumed the role of Principal Investigator for the STOP-PKD Study, succeeding Prof.Vedat Schwenger.

The  team remains always available to support patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) who are interested in learning more about the study. Patients may contact the Stuttgart trial site to schedule an appointment and receive detailed information about the trial, including eligibility requirements and potential participation.

Phone: +49 711 278-35356

Email: studienzentrum-ne